Universitätsklinikum Schleswig-Holstein, Campus Kiel (UKSH) — Kiel

Public research footprint of Universitätsklinikum Schleswig-Holstein, Campus Kiel (UKSH), compiled from the ClinicalTrials.gov public registry.

157

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

CIDP - Chronic Inflammatory Demyelinating Polyneuropathy · ACS (Acute Coronary Syndrome) · Ischemic Heart Disease · Mitral Valve Regurgitation

Recently updated registry entries

NCT06424288 — A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With… (Recruiting)
NCT06872892 — The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With… (Recruiting)
NCT06935370 — A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Universitätsklinikum Schleswig-Holstein, Campus Kiel (UKSH)?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 07, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.